After signing up, you'll start to receive regular news updates from us.
Beckman Announces Sale of Minority Interest in Agencourt Personal Genomics
Complete the form below to unlock access to ALL audio articles.
Beckman Coulter, Inc. has announced it has entered into an agreement to sell the company's minority interest in Agencourt Personal Genomics (APG).
This follows from an agreement between APG and Applied Biosystems Group, an Applera Corporation business whereby Applied Biosystems will acquire APG subject to regulatory and other customary closing conditions.
Beckman Coulter acquired shares of APG in conjunction with its acquisition of Agencourt Bioscience in May 2005.
Beckman Coulter expects to receive about $50 million in cash from the transaction which is anticipated to close in the third quarter of 2006.
